BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36484692)

  • 1. Neurological complications of COVID-19.
    Dai X; Cao X; Jiang Q; Wu B; Lou T; Shao Y; Hu Y; Lan Q
    QJM; 2023 Mar; 116(3):161-180. PubMed ID: 36484692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain.
    Li Z; Liu T; Yang N; Han D; Mi X; Li Y; Liu K; Vuylsteke A; Xiang H; Guo X
    Front Med; 2020 Oct; 14(5):533-541. PubMed ID: 32367431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
    Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
    J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological complications and infection mechanism of SARS-COV-2.
    Wan D; Du T; Hong W; Chen L; Que H; Lu S; Peng X
    Signal Transduct Target Ther; 2021 Nov; 6(1):406. PubMed ID: 34815399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
    Harapan BN; Yoo HJ
    J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinvasion of severe acute respiratory syndrome corona virus-2 (SARS-CoV-2): future risk of epilepsy.
    Kumar H; Gupta R
    Int J Neurosci; 2024 Apr; 134(4):323-332. PubMed ID: 35815479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2.
    Yang F; Zhao H; Liu H; Wu X; Li Y
    Brain Res Bull; 2021 Dec; 177():155-163. PubMed ID: 34571039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological manifestations of coronavirus disease 2019: exploring past to understand present.
    Desai I; Manchanda R; Kumar N; Tiwari A; Kumar M
    Neurol Sci; 2021 Mar; 42(3):773-785. PubMed ID: 33428055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic.
    Sharifian-Dorche M; Huot P; Osherov M; Wen D; Saveriano A; Giacomini PS; Antel JP; Mowla A
    J Neurol Sci; 2020 Oct; 417():117085. PubMed ID: 32871412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological associations of COVID-19.
    Ellul MA; Benjamin L; Singh B; Lant S; Michael BD; Easton A; Kneen R; Defres S; Sejvar J; Solomon T
    Lancet Neurol; 2020 Sep; 19(9):767-783. PubMed ID: 32622375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2: is there neuroinvasion?
    McQuaid C; Brady M; Deane R
    Fluids Barriers CNS; 2021 Jul; 18(1):32. PubMed ID: 34261487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathogenesis of acute coronavirus disease 2019.
    Farhadian SF; Seilhean D; Spudich S
    Curr Opin Neurol; 2021 Jun; 34(3):417-422. PubMed ID: 33852526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncovering a neurological protein signature for severe COVID-19.
    El-Agnaf O; Bensmail I; Al-Nesf MAY; Flynn J; Taylor M; Majbour NK; Abdi IY; Vaikath NN; Farooq A; Vemulapalli PB; Schmidt F; Ouararhni K; Al-Siddiqi HH; Arredouani A; Wijten P; Al-Maadheed M; Mohamed-Ali V; Decock J; Abdesselem HB
    Neurobiol Dis; 2023 Jun; 182():106147. PubMed ID: 37178811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological manifestations and pathogenic mechanisms of COVID-19.
    Galea M; Agius M; Vassallo N
    Neurol Res; 2022 Jul; 44(7):571-582. PubMed ID: 34986754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuro-COVID-19: an insidious virus in action.
    Bratosiewicz-Wąsik J
    Neurol Neurochir Pol; 2022; 56(1):48-60. PubMed ID: 34642927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological Involvements of SARS-CoV2 Infection.
    Gasmi A; Tippairote T; Mujawdiya PK; Gasmi Benahmed A; Menzel A; Dadar M; Bjørklund G
    Mol Neurobiol; 2021 Mar; 58(3):944-949. PubMed ID: 33064267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurointensive care medicine and COVID-19].
    Dimitriadis K; Schmidbauer M; Bösel J
    Nervenarzt; 2023 Feb; 94(2):84-92. PubMed ID: 36520214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.